Visikol Featured in Rutgers Magazine
Visikol was featured this week in the Rutgers Magazine on page 40. The company can trace its roots back to Rutgers where it originally developed its Visikol HISTO technology. The company is now focused on leveraging its proprietary tissue imaging technologies through its 3Screen service to help accelerate drug discovery. Visikol has shown that its 3Screen services dramatically improve the the amount and completeness of data that can be acquired from in vitro cell culture models as well as whole mount tissues.